Management of chronic thromboembolic pulmonary hypertension
Christoph B. Wiedenroth(Kerckhoff Klinik), Michael M. Madani(University of California San Diego), Joanna Pepke‐Żaba(Papworth Hospital NHS Foundation Trust), Victor Pretorius(University of California San Diego), Hiromi Matsubara(Okayama Medical Center), Marc de Perrot(University Health Network), Philippe Brénot(Inserm), Marion Delcroix(American Institute of Biological Sciences), David P. Jenkins(Papworth Hospital NHS Foundation Trust), Zachary L. Steinberg(University of Washington), Hiroto Shimokawahara(National Hospital Organization), Iréne Lang(Medical University of Vienna), Kim M. Kerr(University of California San Diego), Xavier Jaïs(Hôpital Antoine-Béclère), Gérald Simonneau(Inserm), Eckhard Mayer(Kerckhoff Klinik), Ehtisham Mahmud(Cardiovascular Institute of the South), Richard Channick(Harvard University), David Poch(University of California System)
Cited by 6
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Clinical classification of pulmonary hypertension
|Journal of the American College of Cardiology|2004|1.9k
Inhaled Iloprost for Severe Pulmonary Hypertension
|New England Journal of Medicine|2002|1.8k
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
|New England Journal of Medicine|2013|1.4k
Pulmonary hypertension in chronic lung disease and hypoxia
|European Respiratory Journal|2018|777